Cellbricks Therapeutics

Seed
cellbricks.com Biotech & Healthcare Berlin, Germany
Total Funding $11.6M
Latest Round $11.6M Seed
Last Announced Mar 25, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Cellbricks Therapeutics

Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Berlin, Germany
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website cellbricks.com
Domain Registered Date Aug 30, 2013

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $11,590,000 · Seed

    news.google.com

  2. Milestone

    Website domain registered

    cellbricks.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Cellbricks Therapeutics.

Funding History

1 Round
Seed equity · Mar 25, 2026
$11,590,000 news.google.com

Founders & Leadership

4

Alexander Leutner

Founder

Work email & phone locked Unlock →

Alexander Thomas

Founder

Work email & phone locked Unlock →

Lutz Kloke

Founder

Work email & phone locked Unlock →

Tobias Lam

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts